Similar Articles
1441 A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese population
1442 Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells
1443 Hepatitis E: Epidemiology and prevention
1444 Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated?
1445 Hepatitis B virus infection and the risk of hepatocellular carcinoma
1446 Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma
1447 Liver transplantation for hepatocellular carcinoma on cirrhosis: Strategies to avoid tumor recurrence
1448 Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury
1449 Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization
1450 CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA